CareMax (CMAX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

CMAX Stock Forecast

CareMax stock forecast is as follows: an average price target of $2.60 (represents a 289.86% upside from CMAX’s last price of $0.67) and a rating consensus of 'Hold', based on 2 wall street analysts offering a 1-year stock forecast.

CMAX Price Target

The average price target for CareMax (CMAX) is $2.60 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $3.00 to $2.20. This represents a potential 289.86% upside from CMAX's last price of $0.67.

CMAX Analyst Ratings

Hold

According to 2 Wall Street analysts, CareMax's rating consensus is 'Hold'. The analyst rating breakdown for CMAX stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 2 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

CareMax Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Jul 14, 2024	AJ Rice	UBS	$2.20	$2.15	2.33%	229.88%
Apr 12, 2024	Jack Slevin	Jefferies	$3.00	$2.88	4.17%	349.84%
Apr 01, 2024	AJ Rice	UBS	$6.40	$4.82	32.78%	859.66%
Jan 06, 2023	-	UBS	$6.00	$3.61	66.20%	799.69%

Row per page

Go to

The latest CareMax stock forecast, released on Jul 14, 2024 by AJ Rice from UBS, set a price target of $2.20, which represents a 2.33% increase from the stock price at the time of the forecast ($2.15), and a 229.88% increase from CMAX last price ($0.67).

CareMax Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	3
Avg Price Target	-	-	$3.87
Last Closing Price	$0.67	$0.67	$0.67
Upside/Downside	-100.00%	-100.00%	480.30%

In the current month, the average price target of CareMax stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to CareMax's last price of $0.67. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Jul 14, 2024	UBS	Neutral	Neutral	Hold
Apr 12, 2024	Jefferies	Hold	Hold	Hold
Apr 01, 2024	UBS	Neutral	Neutral	Hold
Jan 06, 2023	UBS	Buy	Buy	Hold

Row per page

Go to

CareMax's last stock rating was published by UBS on Jul 14, 2024. The company gave CMAX a "Neutral" rating, the same as its previous rate.

CareMax Financial Forecast

CareMax Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$151.84M	$201.84M	$224.44M	$172.98M	$164.26M	$157.67M	$172.28M	$136.92M	$118.31M	$104.62M	$44.92M
Avg Forecast	$331.71M	$334.80M	$372.20M	$344.27M	$318.66M	$318.03M	$349.78M	$253.92M	$176.78M	$178.57M	$221.40M	$197.24M	$189.69M	$194.45M	$184.41M	$175.97M	$149.70M	$141.05M	$136.21M	$130.06M	$118.36M	$108.30M	$114.54M
High Forecast	$331.71M	$334.80M	$372.20M	$344.27M	$318.66M	$318.03M	$349.78M	$253.92M	$176.78M	$178.57M	$221.40M	$197.24M	$189.78M	$194.74M	$184.41M	$175.97M	$149.70M	$141.05M	$136.21M	$130.06M	$118.36M	$108.30M	$114.54M
Low Forecast	$331.71M	$334.80M	$372.20M	$344.27M	$318.66M	$318.03M	$349.78M	$253.92M	$176.78M	$178.57M	$221.40M	$197.24M	$189.60M	$194.16M	$184.41M	$175.97M	$149.70M	$141.05M	$136.21M	$130.06M	$118.36M	$108.30M	$114.54M
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	3	1	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.80%	1.04%	1.22%	0.98%	1.10%	1.12%	1.26%	1.05%	1.00%	0.97%	0.39%

CareMax's average Quarter revenue forecast for Mar 24 based on 1 analysts is $197.24M, with a low forecast of $197.24M, and a high forecast of $197.24M. CMAX's average Quarter revenue forecast represents a 29.90% increase compared to the company's last Quarter revenue of $151.84M (Dec 23).

CareMax EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	3	1	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-476.14M	$-110.47M	$-38.92M	$-4.09M	$1.53M	$-3.40M	$8.55M	$-6.03M	$10.38M	$3.62M	$-6.71M
Avg Forecast	$-38.56M	$-38.92M	$-43.27M	$-40.02M	$-37.05M	$-36.97M	$-40.66M	$-29.52M	$-20.55M	$-20.76M	$-25.74M	$-22.93M	$-22.05M	$-22.61M	$-21.44M	$-20.46M	$-17.40M	$-626.10K	$-604.60K	$-66.33M	$-525.39K	$-480.75K	$-23.97M
High Forecast	$-38.56M	$-38.92M	$-43.27M	$-40.02M	$-37.05M	$-36.97M	$-40.66M	$-29.52M	$-20.55M	$-20.76M	$-25.74M	$-22.93M	$-22.04M	$-22.57M	$-21.44M	$-20.46M	$-17.40M	$-626.10K	$-604.60K	$-53.06M	$-525.39K	$-480.75K	$-19.17M
Low Forecast	$-38.56M	$-38.92M	$-43.27M	$-40.02M	$-37.05M	$-36.97M	$-40.66M	$-29.52M	$-20.55M	$-20.76M	$-25.74M	$-22.93M	$-22.06M	$-22.64M	$-21.44M	$-20.46M	$-17.40M	$-626.10K	$-604.60K	$-79.59M	$-525.39K	$-480.75K	$-28.76M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	21.59%	4.89%	1.82%	0.20%	-0.09%	5.43%	-14.14%	0.09%	-19.75%	-7.53%	0.28%

1 analysts predict CMAX's average Quarter EBITDA for Mar 23 to be $-20.46M, with a high of $-20.46M and a low of $-20.46M. This is -1440.61% lower than CareMax's previous annual EBITDA (Dec 22) of $1.53M.

CareMax Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	3	1	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-465.77M	$-103.12M	$-32.38M	$-82.08M	$10.43M	$-22.05M	$-9.38M	$-16.80M	$2.24M	$-2.85M	$-7.36M
Avg Forecast	$-3.57M	$-5.03M	$-6.75M	$-7.79M	$-14.99M	$-17.71M	$-21.77M	$-15.50M	$-27.31M	$-30.32M	$-31.44M	$-31.46M	$-18.00M	$-12.50M	$-9.66M	$-14.10M	$-7.47M	$-7.27M	$-6.83M	$-113.38M	$-7.79M	$-9.42M	$-29.82M
High Forecast	$-3.57M	$-5.03M	$-6.75M	$-7.79M	$-14.99M	$-17.71M	$-21.77M	$-15.50M	$-27.31M	$-30.32M	$-31.44M	$-31.46M	$-18.00M	$-12.50M	$-9.66M	$-14.10M	$-7.47M	$-7.27M	$-6.83M	$-90.70M	$-7.79M	$-9.42M	$-23.86M
Low Forecast	$-3.57M	$-5.03M	$-6.75M	$-7.79M	$-14.99M	$-17.71M	$-21.77M	$-15.50M	$-27.31M	$-30.32M	$-31.44M	$-31.46M	$-18.00M	$-12.50M	$-9.66M	$-14.10M	$-7.47M	$-7.27M	$-6.83M	$-136.06M	$-7.79M	$-9.42M	$-35.79M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	25.87%	8.25%	3.35%	5.82%	-1.40%	3.03%	1.37%	0.15%	-0.29%	0.30%	0.25%

CareMax's average Quarter net income forecast for Mar 23 is $-14.10M, with a range of $-14.10M to $-14.10M. CMAX's average Quarter net income forecast represents a -235.11% decrease compared to the company's last Quarter net income of $10.43M (Dec 22).

CareMax SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	3	1	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$20.34M	$22.78M	$24.12M	$27.71M	$20.90M	$24.04M	$20.36M	$22.28M	$18.93M	$14.86M	$9.66M
Avg Forecast	$57.20M	$57.73M	$64.18M	$59.36M	$54.95M	$54.84M	$60.31M	$43.78M	$30.48M	$30.79M	$38.18M	$34.01M	$32.71M	$33.53M	$31.80M	$30.34M	$25.81M	$45.60M	$44.03M	$42.05M	$38.27M	$35.01M	$39.11M
High Forecast	$57.20M	$57.73M	$64.18M	$59.36M	$54.95M	$54.84M	$60.31M	$43.78M	$30.48M	$30.79M	$38.18M	$34.01M	$32.72M	$33.58M	$31.80M	$30.34M	$25.81M	$45.60M	$44.03M	$42.05M	$38.27M	$35.01M	$46.93M
Low Forecast	$57.20M	$57.73M	$64.18M	$59.36M	$54.95M	$54.84M	$60.31M	$43.78M	$30.48M	$30.79M	$38.18M	$34.01M	$32.69M	$33.48M	$31.80M	$30.34M	$25.81M	$45.60M	$44.03M	$42.05M	$38.27M	$35.01M	$31.29M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.62%	0.68%	0.76%	0.91%	0.81%	0.53%	0.46%	0.53%	0.49%	0.42%	0.25%

CareMax's average Quarter SG&A projection for Mar 24 is $34.01M, based on 1 Wall Street analysts, with a range of $34.01M to $34.01M. The forecast indicates a 67.18% rise compared to CMAX last annual SG&A of $20.34M (Dec 23).

CareMax EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	1	1	1	1	1	3	1	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.12	$-0.92	$-0.29	$-0.74	$0.10	$-0.25	$-0.11	$-0.19	$0.03	$-0.03	$-0.26
Avg Forecast	$-0.94	$-1.32	$-1.77	$-2.05	$-3.94	$-4.65	$-5.72	$-4.07	$-7.17	$-7.96	$-8.26	$-8.26	$-4.73	$-3.28	$-2.54	$-3.70	$-1.96	$-1.91	$-1.79	$-0.42	$-2.05	$-2.48	$-1.20
High Forecast	$-0.94	$-1.32	$-1.77	$-2.05	$-3.94	$-4.65	$-5.72	$-4.07	$-7.17	$-7.96	$-8.26	$-8.26	$-4.73	$-3.28	$-2.54	$-3.70	$-1.96	$-1.91	$-1.79	$-0.42	$-2.05	$-2.48	$-1.20
Low Forecast	$-0.94	$-1.32	$-1.77	$-2.05	$-3.94	$-4.65	$-5.72	$-4.07	$-7.17	$-7.96	$-8.26	$-8.26	$-4.73	$-3.28	$-2.54	$-3.70	$-1.96	$-1.91	$-1.79	$-0.42	$-2.05	$-2.48	$-1.20
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.03%	0.28%	0.11%	0.20%	-0.05%	0.13%	0.06%	0.46%	-0.01%	0.01%	0.22%

According to 1 Wall Street analysts, CareMax's projected average Quarter EPS for Mar 23 is $-3.70, with a low estimate of $-3.70 and a high estimate of $-3.70. This represents a -3802.41% decrease compared to CMAX previous annual EPS of $0.10 (Dec 22).

CareMax Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
CMAX	CareMax	$0.67	$2.60	288.06%	Hold
HCAT	Health Catalyst	$7.66	$29.25	281.85%	Buy
EVH	Evolent Health	$11.59	$40.86	252.55%	Buy
FORA	Forian	$2.09	$4.50	115.31%	Buy
CERT	Certara	$9.77	$19.33	97.85%	Buy
PRVA	Privia Health Group	$21.08	$33.82	60.44%	Buy
HQY	HealthEquity	$104.65	$97.00	-7.31%	Buy
HSTM	HealthStream	$31.82	$29.00	-8.86%	Buy

CMAX Forecast FAQ

Is CareMax a good buy?

No, according to 2 Wall Street analysts, CareMax (CMAX) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of CMAX's total ratings.

What is CMAX's price target?

CareMax (CMAX) average price target is $2.6 with a range of $2.2 to $3, implying a 289.86% from its last price of $0.667. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will CareMax stock go up soon?

According to Wall Street analysts' prediction for CMAX stock, the company can go up by 289.86% (from the last price of $0.667 to the average price target of $2.6), up by 349.84% based on the highest stock price target, and up by 229.88% based on the lowest stock price target.

Can CareMax stock reach $1?

CMAX's average twelve months analyst stock price target of $2.6 supports the claim that CareMax can reach $1 in the near future.

What are CareMax's analysts' financial forecasts?

CareMax's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.24B (high $1.24B, low $1.24B), average EBITDA is $-144M (high $-144M, low $-144M), average net income is $-69.967M (high $-69.967M, low $-69.967M), average SG&A $213.88M (high $213.88M, low $213.88M), and average EPS is $-18.376 (high $-18.376, low $-18.376). CMAX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.38B (high $1.38B, low $1.38B), average EBITDA is $-161M (high $-161M, low $-161M), average net income is $-23.154M (high $-23.154M, low $-23.154M), average SG&A $238.47M (high $238.47M, low $238.47M), and average EPS is $-6.081 (high $-6.081, low $-6.081).

Did the CMAX's actual financial results beat the analysts' financial forecasts?

Based on CareMax's last annual report (Dec 2023), the company's revenue was $751.1M, beating the average analysts forecast of $744.52M by 0.88%. Apple's EBITDA was $-711M, beating the average prediction of $-86.555M by 721.28%. The company's net income was $-683M, beating the average estimation of $-54.254M by 1159.53%. Apple's SG&A was $94.96M, missing the average forecast of $128.38M by -26.03%. Lastly, the company's EPS was $-0.18, missing the average prediction of $-14.249 by -98.74%. In terms of the last quarterly report (Dec 2023), CareMax's revenue was $151.84M, missing the average analysts' forecast of $189.69M by -19.96%. The company's EBITDA was $-476M, beating the average prediction of $-22.053M by 2059.05%. CareMax's net income was $-466M, beating the average estimation of $-18.001M by 2487.49%. The company's SG&A was $20.34M, missing the average forecast of $32.71M by -37.81%. Lastly, the company's EPS was $-0.12, missing the average prediction of $-4.728 by -97.46%